(Q37587790)

21 August 2017

1 reference

title

Formation and development of Lewy pathology: a critical update (English)

1 reference

21 August 2017

0 references

Kurt A Jellinger

1

1 reference

21 August 2017

publication date

1 August 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

256 Suppl 3

1 reference

21 August 2017

page(s)

270-279

1 reference

Cognitive status correlates with neuropathologic stage in Parkinson disease.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5243-Y

Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): relationship to parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5243-Y

Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5243-Y

A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5243-Y

Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5243-Y

Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5243-Y

Emerging evidence for the neuroprotective role of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5243-Y

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5243-Y

Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5243-Y

Synucleinopathies: clinical and pathological implications

21 January 2018

1 reference

12 December 2020

Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease

1 reference

12 December 2020

Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium.

1 reference

12 December 2020

Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases

1 reference

12 December 2020

Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

1 reference

12 December 2020

Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease

1 reference

12 December 2020

Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies

1 reference

12 December 2020

Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease

1 reference

12 December 2020

Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo.

1 reference

12 December 2020

Relationships between Lewy bodies and pale bodies in Parkinson's disease

1 reference

12 December 2020

Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects

1 reference

12 December 2020

New insights into the pathology of Parkinson's disease: does the peripheral autonomic system become central?

1 reference

12 December 2020

Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems

1 reference

12 December 2020

Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease

1 reference

12 December 2020

Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient

1 reference

12 December 2020

Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.

1 reference

12 December 2020

A critical reappraisal of current staging of Lewy-related pathology in human brain

1 reference

12 December 2020

Animal models of Parkinson's disease progression

1 reference

12 December 2020

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

1 reference

12 December 2020

Incidental Lewy body disease and preclinical Parkinson disease

1 reference

12 December 2020

Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain

1 reference

12 December 2020

Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease

1 reference

12 December 2020

Expression of Lewy body protein septin 4 in postmortem brain of Parkinson's disease and control subjects.

1 reference

12 December 2020

Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study

1 reference

12 December 2020

The etiopathogenesis of Parkinson disease and suggestions for future research. Part I.

1 reference

12 December 2020

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

1 reference

12 December 2020

Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death

1 reference

12 December 2020

In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution

1 reference

12 December 2020

Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability

1 reference

12 December 2020

Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective

1 reference

12 December 2020

Synaptic plasticity, dopamine and Parkinson's disease: one step ahead

1 reference

12 December 2020

Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusions

1 reference

12 December 2020

Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects

1 reference

12 December 2020

1 reference

12 December 2020

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

1 reference

12 December 2020

Nigral burden of alpha-synuclein correlates with striatal dopamine deficit

1 reference

12 December 2020

Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered

1 reference

12 December 2020

Proteomic identification of novel proteins in cortical lewy bodies

1 reference

12 December 2020

Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies

1 reference

12 December 2020

Lewy body cortical involvement may not always predict dementia in Parkinson's disease

1 reference

12 December 2020

Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease.

1 reference

12 December 2020

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

1 reference

12 December 2020

Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study.

1 reference

12 December 2020

Alzheimer disease pathology as a host response

1 reference

12 December 2020

Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy

1 reference

12 December 2020

Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study

1 reference

12 December 2020

The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease.

1 reference

12 December 2020

Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra

1 reference

12 December 2020

Cortical Lewy body pathology in the diagnosis of dementia

1 reference

12 December 2020

Three-layered structure shared between Lewy bodies and lewy neurites-three-dimensional reconstruction of triple-labeled sections

1 reference

12 December 2020

A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen

1 reference

12 December 2020

A critical evaluation of the Braak staging scheme for Parkinson's disease.

1 reference

12 December 2020

Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation

1 reference

12 December 2020

Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred

1 reference

12 December 2020

Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject.

1 reference

12 December 2020

Relating mode of action to clinical practice: dopaminergic agents in Parkinson's disease

1 reference

12 December 2020

Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.

1 reference

12 December 2020

Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study

1 reference

12 December 2020

Lewy body pathology in normal elderly subjects

1 reference

12 December 2020

Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies.

1 reference

12 December 2020

A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death

1 reference

12 December 2020

Controversies over the staging of alpha-synuclein pathology in Parkinson's disease

1 reference

12 December 2020

Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.

1 reference

12 December 2020

Interface between tauopathies and synucleinopathies: A tale of two proteins

1 reference

12 December 2020

Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies

1 reference

12 December 2020

Parkinson's disease: premotor clinico-pathological correlations

1 reference

12 December 2020

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

12 December 2020

Neurofibrillary tau pathology modulated by genetic variation of alpha-synuclein.

1 reference

12 December 2020

More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases

1 reference

12 December 2020

Research in motion: the enigma of Parkinson's disease pathology spread

1 reference

12 December 2020

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

12 December 2020

The progression of pathology in longitudinally followed patients with Parkinson's disease.

1 reference

12 December 2020

Alpha-synuclein dysfunction in Lewy body diseases

1 reference

12 December 2020

Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance

1 reference

12 December 2020

Invited Article: Nervous system pathology in sporadic Parkinson disease

1 reference

12 December 2020

Assessment of α-Synuclein Pathology: A Study of the BrainNet Europe Consortium

1 reference

12 December 2020

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S00415-009-5243-Y

Identifiers

DOI

1 reference

21 August 2017

1 reference